Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by Hempdocon Oct 01, 2020 5:08pm

142 Views

Post# 31655190

PDT Potential Against Infection

PDT is shining a new light against the harsh realities of growing bacterial resistance...this is a promising example of nasal PDT to prevent secondary infection. This technology will undoubtedly expand deeper into the airways to both prevent & fight infection imo. TLT could perhaps benefit from a similar (though expanded) approach in its fight against Covid & other viral/bacterial respiratory illnesses....

https://t.co/cy0nqploZ7?amp=1

Bullboard Posts

Two Venture-listed mining stocks file NI 43-101 reports